ANGELA WOODMAN: Open Payments
NPI 1063176345 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 70 payments from 14 companies in 2025. Trend: 2023 $30 · 2024 $510 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $357 |
| Alkermes, Inc. | 4 | $104 |
| Braeburn Inc. | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Almatica Pharma LLC | 4 | $75 |
| Indivior Inc. | 2 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Corium, LLC | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
Products named: VRAYLAR, BRIXADI, Auvelity, LOREEV XR, SUBLOCADE, SPRAVATO, LYBALVI, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
